Range
14.38 - 14.58
Vol / Avg.
15.8K/1.3M
Div / Yield
-
52 Wk
11.8 - 29.65
Mkt Cap
718.2M
Payout Ratio
-
Open
14.58
P/E
44.09
EPS
-0.47
Shares
50.1M
Outstanding
50.1M
Total Float
49.1M
Sector: Health Care.Industry: Pharmaceuticals
Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.590-0.470 0.1200
REV2.360M1.935M-425.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CARACara Therapeutics-1.37%718.2M

Cara Therapeutics Frequently Asked Questions

Q

How do I buy Cara Therapeutics (CARA) stock?

A

You can purchase shares of Cara Therapeutics (NASDAQ: CARA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cara Therapeutics's (CARA) competitors?

Q

What is the target price for Cara Therapeutics (CARA) stock?

A

The latest price target for Cara Therapeutics (NASDAQ: CARA) was reported by Needham on April 29, 2021. The analyst firm set a price target for 26.00 expecting CARA to rise to within 12 months (a possible 81.18% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cara Therapeutics (CARA)?

A

The stock price for Cara Therapeutics (NASDAQ: CARA) is $14.35 last updated Today at 1:38:15 PM.

Q

Does Cara Therapeutics (CARA) pay a dividend?

A

There are no upcoming dividends for Cara Therapeutics.

Q

When is Cara Therapeutics (NASDAQ:CARA) reporting earnings?

A
Cara Therapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Cara Therapeutics (CARA) going to split?

A

There is no upcoming split for Cara Therapeutics.

Q

What sector and industry does Cara Therapeutics (CARA) operate in?

A

Cara Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.